Applied Molecular Pathology Laboratory

在过去的财政年度，BSI-II在实验室内部分实施，用于跟踪和清点要构建的组织块和TMA。人类组织的第一个试点项目--在波兰乳腺癌研究中构建TMA--已经成功完成。几个较小的乳腺癌相关项目已经完成。团队中又增加了一名兼职病理学家，以提高实验室的产出。计划中的肺癌研究尚未开始。对项目的跟踪有所改善。随着试点项目的成功，我们正在采取下一步措施，将核心提供给其他研究和调查人员，为可能的研究确定优先事项，并制定治理指导方针。谢尔曼博士已经离开DCEG，但仍是一名兼职调查员。

This past fiscal year, BSI-II was partially implemented within the lab for tracking and inventorying the tissue blocks and TMAs to be constructed. The first pilot project in human tissue, TMA construction within the Polish Breast Cancer Study, has been successfully completed. Several smaller breast cacner related projects were completed. An additional part-time pathologist was added to the team to incl=rease the output of the lab. The planned lung cancer study has not been started yet. Tracking of projects has improved. WIth the success of the pilot project, we are taking the next steps to make the core available to other studies and investigators, setting priorities for the possible studies, and developing governance guidelines. Dr. Sherman has left DCEG, but is still an adjunct investigator.